SRZN - Surrozen, Inc./DE

QQQ $ 441.71 $ 1.04 (0.24 %)

DIA $ 395.04 $ 1.18 (0.3 %)

SPY $ 520.76 $ 0.67 (0.13 %)

TLT $ 90.14 $ -0.51 (-0.56 %)

GLD $ 218.73 $ 1.76 (0.81 %)

Previous Close

$ 10.3999

Open

$ 9.92

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 9.92 - $ 9.92

52 Week Range

$ 4.50 - $ 16.19

Volume

22,834

Average Volume

Market Cap

21.66M

Beta (5Y Monthly)

$ 0.77

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-08-2024	03-31-2024	10-Q
2	04-10-2024	12-31-2023	10-K
3	11-08-2023	09-30-2023	10-Q
4	08-09-2023	06-30-2023	10-Q
5	05-10-2023	03-31-2023	10-Q
6	03-31-2023	12-31-2022	10-K
7	11-14-2022	09-30-2022	10-Q
8	08-11-2022	06-30-2022	10-Q
9	05-11-2022	03-31-2022	10-Q
10	03-28-2022	12-31-2021	10-K
11	11-15-2021	09-30-2021	10-Q
12	08-06-2021	06-30-2021	10-Q
13	05-24-2021	03-31-2021	10-Q
14	03-31-2021	12-31-2020	10-K
15	01-04-2021	09-30-2020	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Surrozen Presents Data Demonstrating The P...
05/09/2024 13:21:17

In preclinical models of cornea endothelial dystrophies, a Surrozen antibody-based Wnt mimetic reduced corneal edema and stimul...

Surrozen Q1 EPS $(4.24) Beats $(4.25) Esti...
05/08/2024 21:11:24

Surrozen (NASDAQ:SRZN) reported quarterly losses of $(4.24) per share which beat the analyst consensus estimate of $(4.25) by 0...

RA Capital Management Reports 9.99% Passiv...
04/15/2024 20:54:05

Surrozen Publishes Study In 'Respiratory R...
04/03/2024 12:41:39

why-nuvve-holding-shares-are-trading-lower-by-around-30-here-are-other-stocks-moving-in-mondays-mid-day-session

Why Nuvve Holding Shares Are Trading Lower...
04/01/2024 18:31:11

Shares of Nuvve Holding Corp. (NASDAQ: NVVE) fell sharply during Monday’s session after the company reported worse-than-expect...

why-is-regenerative-medicine-focused-surrozen-stock-trading-lower-on-monday

Why Is Regenerative Medicine-Focused Surro...
04/01/2024 17:14:04

Surrozen engages in a private placement, aiming to raise approximately $192.5 million in gross proceeds. Updates on SZN-043 Pha...

Surrozen Announces Safety, Pharmacodynamic...
04/01/2024 12:36:18

Surrozen Announces Up To $192.5M Private P...
04/01/2024 12:31:47

Surrozen Provides Corporate Update On Clin...
01/18/2024 13:31:27

Announces strategic prioritization of clinical programs to focus on development of SZN-043 for Alcohol-Associated HepatitisSZN-...

Surrozen Shares To Resume Trading At 09:00...
12/14/2023 13:58:40

12-health-care-stocks-moving-in-tuesdays-after-market-session

12 Health Care Stocks Moving In Tuesday's ...
12/05/2023 21:31:06

12-health-care-stocks-moving-in-wednesdays-after-market-session

12 Health Care Stocks Moving In Wednesday'...
11/15/2023 21:31:03

Surrozen Q3 EPS $(0.34) Misses $(0.29) Est...
11/08/2023 22:08:59

Surrozen (NASDAQ:SRZN) reported quarterly losses of $(0.34) per share which missed the analyst consensus estimate of $(0.29) by...

12-health-care-stocks-moving-in-thursdays-after-market-session

12 Health Care Stocks Moving In Thursday's...
09/21/2023 21:31:45

12-health-care-stocks-moving-in-thursdays-intraday-session

12 Health Care Stocks Moving In Thursday's...
08/10/2023 17:31:06

Why Krispy Kreme Shares Are Trading Lower ...
08/10/2023 17:17:29

Gainers Edible Garden AG Incorporated (NASDAQ: EDBL) shares jumped 58% to $1.88 after the company reported better-than-expe...

Surrozen Q2 EPS $(0.31) Up From $(0.40) YoY
08/09/2023 21:16:20

Surrozen (NASDAQ:SRZN) reported quarterly losses of $(0.31) per share. This is a 22.5 percent increase over losses of $(0.40) p...

Surrozen Highlights Study Published In Nat...
06/05/2023 12:32:08

Surrozen: Q1 Earnings Insights
05/10/2023 21:45:11

Surrozen Q1 EPS $(0.48) Misses $(0.35) Est...
05/10/2023 20:44:54

Surrozen (NASDAQ:SRZN) reported quarterly losses of $(0.48) per share which missed the analyst consensus estimate of $(0.35) by...